| Year |
Citation |
Score |
| 2008 |
Matloub Y, Gaynon PS, Jayabose S, Bostrom BC, Hunger SP, Angiolillo AL, Devidas M, Linda S, Carroll WL, Winick N, Sather H, Pine SR. Bone Marrow (BM) Minimal Residual Disease (MRD) at End of Induction and Interim Maintenance Is Highly Predictive of Outcome in Children with Standard Risk (SR) Acute Lymphoblastic Leukemia (ALL) Treated on the Children’s Oncology Group Study 1991 Blood. 112: 701-701. DOI: 10.1182/Blood.V112.11.701.701 |
0.323 |
|
| 2007 |
Pine SR, Guo Q, Yin C, Jayabose S, Druschel CM, Sandoval C. Incidence and clinical implications of GATA1 mutations in newborns with Down syndrome. Blood. 110: 2128-31. PMID 17576817 DOI: 10.1182/Blood-2007-01-069542 |
0.364 |
|
| 2007 |
Jayabose S, Levendoglu-Tugal O, Ozkaynak MF, Pine S, Sandoval C. A Case of Relapsed Down Syndrome–Associated Acute Megakaryoblastic Leukemia Cured with Non-Myeloablative Chemotherapy Clinical Leukemia. 1: 309-312. DOI: 10.3816/Clk.2007.N.023 |
0.37 |
|
| 2006 |
Sandoval C, Pine SR, Druschel C, Jayabose S, Guo Q, Yin C. GATA1 Mutations in Newborns with Down Syndrome. Blood. 108: 641-641. DOI: 10.1182/Blood.V108.11.641.641 |
0.38 |
|
| 2005 |
Pine SR, Guo Q, Yin C, Jayabose S, Levendoglu-Tugal O, Ozkaynak MF, Sandoval C. GATA1 as a new target to detect minimal residual disease in both transient leukemia and megakaryoblastic leukemia of Down syndrome. Leukemia Research. 29: 1353-6. PMID 15916804 DOI: 10.1016/J.Leukres.2005.04.007 |
0.42 |
|
| 2005 |
Pine SR, Yin C, Matloub YH, Sabaawy HE, Sandoval C, Levendoglu-Tugal O, Ozkaynak MF, Jayabose S. Detection of central nervous system leukemia in children with acute lymphoblastic leukemia by real-time polymerase chain reaction. The Journal of Molecular Diagnostics : Jmd. 7: 127-32. PMID 15681484 DOI: 10.1016/S1525-1578(10)60018-9 |
0.354 |
|
| 2005 |
Sandoval C, Pine SR, Guo Q, Sastry S, Stewart J, Kronn D, Jayabose S. Tetrasomy 21 transient leukemia with a GATA1 mutation in a phenotypically normal trisomy 21 mosaic infant: case report and review of the literature. Pediatric Blood & Cancer. 44: 85-91. PMID 15390279 DOI: 10.1002/Pbc.20161 |
0.365 |
|
| 2003 |
Pine SR, Moy FH, Wiemels JL, Gill RK, Levendoglu-Tugal O, Ozkaynak MF, Sandoval C, Jayabose S. Real-time quantitative PCR: standardized detection of minimal residual disease in pediatric acute lymphoblastic leukemia. Polymerase chain reaction. Journal of Pediatric Hematology/Oncology. 25: 103-8. PMID 12571459 DOI: 10.1097/00043426-200302000-00004 |
0.346 |
|
| 2003 |
Pine SR, Wiemels JL, Jayabose S, Sandoval C. TEL-AML1 fusion precedes differentiation to pre-B cells in childhood acute lymphoblastic leukemia. Leukemia Research. 27: 155-64. PMID 12526921 DOI: 10.1016/S0145-2126(02)00183-2 |
0.367 |
|
| 2002 |
Wiemels JL, Leonard BC, Wang Y, Segal MR, Hunger SP, Smith MT, Crouse V, Ma X, Buffler PA, Pine SR. Site-specific translocation and evidence of postnatal origin of the t(1;19) E2A-PBX1 fusion in childhood acute lymphoblastic leukemia. Proceedings of the National Academy of Sciences of the United States of America. 99: 15101-6. PMID 12415113 DOI: 10.1073/Pnas.222481199 |
0.351 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2018 |
Patrizii M, Bartucci M, Pine SR, Sabaawy HE. Utility of Glioblastoma Patient-Derived Orthotopic Xenografts in Drug Discovery and Personalized Therapy. Frontiers in Oncology. 8: 23. PMID 29484285 DOI: 10.3389/Fonc.2018.00023 |
0.284 |
|
| 2007 |
Sandoval C, Pine SR. Down syndrome and GATA1-related transient leukemia. The Journal of Pediatrics. 150: e34. PMID 17307526 DOI: 10.1016/J.Jpeds.2006.10.055 |
0.281 |
|
| 2006 |
Trueworthy RC, Stork L, Zhong Y, Pine S, Matloub Y, Laderas T, McWeeney S, Fan G. Cerebrospinal Fluid (CSF) Proteomics in Children with Acute Lymphoblastic Leukemia (ALL). Blood. 108: 1834-1834. DOI: 10.1182/Blood.V108.11.1834.1834 |
0.278 |
|
| 2019 |
Mitchell KA, Nichols N, Tang W, Walling J, Stevenson H, Pineda M, Stefanescu R, Edelman DC, Girvin AT, Zingone A, Sinha S, Bowman E, Rossi EL, Arauz RF, Jack Zhu Y, ... ... Pine SR, et al. Recurrent PTPRT/JAK2 mutations in lung adenocarcinoma among African Americans. Nature Communications. 10: 5735. PMID 31844068 DOI: 10.1038/S41467-019-13732-Y |
0.256 |
|
| 2015 |
Morgan KM, Lee F, Michaud E, Bertino JR, Fischer BS, Pine SR. Abstract 2535: Synergistic anti-tumor activity of the Notch gamma secretase inhibitor BMS-906024 and paclitaxel in the treatment of lung adenocarcinoma Cancer Research. 75: 2535-2535. DOI: 10.1158/1538-7445.Am2015-2535 |
0.23 |
|
| 2022 |
Malhotra J, Ryan B, Patel M, Chan N, Guo Y, Aisner J, Jabbour SK, Pine S. Clinical outcomes and immune phenotypes associated with co-occurring mutations in non-small cell lung cancer. Journal of Thoracic Disease. 14: 1772-1783. PMID 35813711 DOI: 10.21037/jtd-21-1377 |
0.23 |
|
| 2017 |
Kulkarni A, Al-Hraishawi H, Simhadri S, Hirshfield KM, Chen S, Pine SR, Jeyamohan C, Sokol L, Ali SM, Teo ML, White E, Rodriguez-Rodriguez L, Mehnert JM, Ganesan S. BRAF fusion as a novel mechanism of acquired resistance to vemurafenib in BRAF V600E mutant melanoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28539463 DOI: 10.1158/1078-0432.CCR-16-0758 |
0.225 |
|
| 2019 |
Epsi NJ, Panja S, Pine SR, Mitrofanova A. pathCHEMO, a generalizable computational framework uncovers molecular pathways of chemoresistance in lung adenocarcinoma. Communications Biology. 2: 334. PMID 31925175 DOI: 10.1038/s42003-019-0572-6 |
0.219 |
|
| 2019 |
Epsi NJ, Panja S, Pine SR, Mitrofanova A. pathCHEMO, a generalizable computational framework uncovers molecular pathways of chemoresistance in lung adenocarcinoma. Communications Biology. 2: 334. PMID 31508508 DOI: 10.1038/s42003-019-0572-6 |
0.218 |
|
| 2017 |
Morgan KM, Fischer BS, Lee FY, Shah JJ, Bertino JR, Rosenfeld J, Singh A, Khiabanian H, Pine SR. Gamma secretase inhibition by BMS-906024 enhances efficacy of paclitaxel in lung adenocarcinoma. Molecular Cancer Therapeutics. PMID 28978720 DOI: 10.1158/1535-7163.Mct-17-0439 |
0.215 |
|
| 2017 |
Morgan KM, Riedlinger GM, Rosenfeld J, Ganesan S, Pine SR. Patient-Derived Xenograft Models of Non-Small Cell Lung Cancer and Their Potential Utility in Personalized Medicine. Frontiers in Oncology. 7: 2. PMID 28154808 DOI: 10.3389/Fonc.2017.00002 |
0.211 |
|
| 2019 |
Castellano GM, Aisner J, Burley SK, Vallat B, Yu HA, Pine SR, Ganesan S. A Novel Acquired Exon 20 EGFR M766Q Mutation in Lung Adenocarcinoma Mediates Osimertinib Resistance but is Sensitive to Neratinib and Poziotinib: a Brief Report. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 31254668 DOI: 10.1016/J.Jtho.2019.06.015 |
0.205 |
|
| 2012 |
Patel SA, Ramkissoon SH, Bryan M, Pliner LF, Dontu G, Patel PS, Amiri S, Pine SR, Rameshwar P. Delineation of breast cancer cell hierarchy identifies the subset responsible for dormancy. Scientific Reports. 2: 906. PMID 23205268 DOI: 10.1038/srep00906 |
0.203 |
|
| 2016 |
Hong X, Liu W, Song R, Inuzuka H, Sabaawy HE, Morgan KM, Shah JJ, Bunting SF, Feng X, Tsang C, Shen Z, Zheng XFS, Liu L, Pine SR. Abstract 4544: FBW7 induces S-phase arrest caused by DNA double strand breaks through targeting SOX9 for proteasomal degradation Cancer Research. 76: 4544-4544. DOI: 10.1158/1538-7445.Am2016-4544 |
0.187 |
|
| 2019 |
Garbuzenko OB, Kuzmov A, Taratula O, Pine SR, Minko T. Strategy to enhance lung cancer treatment by five essential elements: inhalation delivery, nanotechnology, tumor-receptor targeting, chemo- and gene therapy. Theranostics. 9: 8362-8376. PMID 31754402 DOI: 10.7150/Thno.39816 |
0.175 |
|
| 2021 |
Wang X, Zhang H, Sapio R, Yang J, Wong J, Zhang X, Guo JY, Pine S, Van Remmen H, Li H, White E, Liu C, Kiledjian M, Pestov DG, Steven Zheng XF. SOD1 regulates ribosome biogenesis in KRAS mutant non-small cell lung cancer. Nature Communications. 12: 2259. PMID 33859191 DOI: 10.1038/s41467-021-22480-x |
0.164 |
|
| 2014 |
Capaccione KM, Hong X, Morgan KM, Liu W, Bishop JM, Liu L, Markert E, Deen M, Minerowicz C, Bertino JR, Allen T, Pine SR. Sox9 mediates Notch1-induced mesenchymal features in lung adenocarcinoma. Oncotarget. 5: 3636-50. PMID 25004243 DOI: 10.18632/Oncotarget.1970 |
0.162 |
|
| 2014 |
Ryan BM, Pine SR, Chaturvedi AK, Caporaso N, Harris CC. A combined prognostic serum interleukin-8 and interleukin-6 classifier for stage 1 lung cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 9: 1494-503. PMID 25170636 DOI: 10.1097/Jto.0000000000000278 |
0.162 |
|
| 2008 |
Pine SR, Marshall B, Varticovski L. Lung cancer stem cells. Disease Markers. 24: 257-66. PMID 18525120 |
0.161 |
|
| 2010 |
Pine SR, Ryan BM, Varticovski L, Robles AI, Harris CC. Microenvironmental modulation of asymmetric cell division in human lung cancer cells. Proceedings of the National Academy of Sciences of the United States of America. 107: 2195-200. PMID 20080668 DOI: 10.1073/pnas.0909390107 |
0.159 |
|
| 2022 |
Castellano GM, Zeeshan S, Garbuzenko O, Sabaawy HE, Malhotra J, Minko T, Pine SR. Inhibition of mTORC1/2 and DNA-PK via CC-115 Synergizes with Carboplatin and Paclitaxel in Lung Squamous Cell Carcinoma. Molecular Cancer Therapeutics. PMID 35732569 DOI: 10.1158/1535-7163.MCT-22-0053 |
0.159 |
|
| 2014 |
Capaccione KM, Hong X, Morgan KM, Allen TD, Miles GD, Markert EK, Bishop JM, Pine SR. Abstract 1149: The role of the novel Notch1-Sox9 signaling axis in NSCLC progression and EMT Cancer Research. 74: 1149-1149. DOI: 10.1158/1538-7445.Am2014-1149 |
0.158 |
|
| 2016 |
Hong X, Liu W, Song R, Shah JJ, Feng X, Tsang CK, Morgan KM, Bunting SF, Inuzuka H, Zheng XF, Shen Z, Sabaawy HE, Liu L, Pine SR. SOX9 is targeted for proteasomal degradation by the E3 ligase FBW7 in response to DNA damage. Nucleic Acids Research. PMID 27566146 DOI: 10.1093/Nar/Gkw748 |
0.155 |
|
| 2021 |
Kwon M, Rubio G, Nolan N, Auteri P, Volmar JA, Adem A, Javidian P, Zhou Z, Verzi MP, Pine SR, Libutti SK. FILIP1L loss is a driver of aggressive mucinous colorectal adenocarcinoma and mediates cytokinesis defects through PFDN1. Cancer Research. PMID 34417201 DOI: 10.1158/0008-5472.CAN-21-0897 |
0.154 |
|
| 2023 |
Bhatt V, Lan T, Wang W, Kong J, Lopes EC, Wang J, Khayati K, Raju A, Rangel M, Lopez E, Hu ZS, Luo X, Su X, Malhotra J, Hu W, ... Pine SR, et al. Inhibition of autophagy and MEK promotes ferroptosis in Lkb1-deficient Kras-driven lung tumors. Cell Death & Disease. 14: 61. PMID 36702816 DOI: 10.1038/s41419-023-05592-8 |
0.152 |
|
| 2020 |
Mitchell KA, Nichols N, Tang W, Walling J, Stevenson H, Pineda M, Stefanescu R, Edelman DC, Girvin AT, Zingone A, Sinha S, Bowman E, Rossi EL, Arauz RF, Zhu YJ, ... ... Pine SR, et al. Author Correction: Recurrent PTPRT/JAK2 mutations in lung adenocarcinoma among African Americans. Nature Communications. 11: 700. PMID 32001692 DOI: 10.1038/S41467-020-14448-0 |
0.152 |
|
| 2010 |
Chaturvedi A, Caporaso N, Katki H, Wong H, Chatterjee N, Pine S, Chanock S, Goedert J, Engels E. Abstract 2789: C-reactive protein and risk of lung cancer Cancer Research. 70: 2789-2789. DOI: 10.1158/1538-7445.Am10-2789 |
0.152 |
|
| 2014 |
Pine SR, Liu W. Asymmetric cell division and template DNA co-segregation in cancer stem cells. Frontiers in Oncology. 4: 226. PMID 25191642 DOI: 10.3389/fonc.2014.00226 |
0.147 |
|
| 2011 |
Pine SR, Mechanic LE, Enewold L, Chaturvedi AK, Katki HA, Zheng YL, Bowman ED, Engels EA, Caporaso NE, Harris CC. Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer. Journal of the National Cancer Institute. 103: 1112-22. PMID 21685357 DOI: 10.1093/Jnci/Djr216 |
0.146 |
|
| 2013 |
Capaccione KM, Pine SR. The Notch signaling pathway as a mediator of tumor survival. Carcinogenesis. 34: 1420-30. PMID 23585460 DOI: 10.1093/carcin/bgt127 |
0.144 |
|
| 2021 |
Sabaawy HE, Ryan BM, Khiabanian H, Pine SR. JAK/STAT of all trades: Linking inflammation with cancer development, tumor progression, and therapy resistance. Carcinogenesis. PMID 34415330 DOI: 10.1093/carcin/bgab075 |
0.141 |
|
| 2011 |
Schwartz AG, Wenzlaff AS, Bock CH, Ruterbusch JJ, Chen W, Cote ML, Artis AS, Van Dyke AL, Land SJ, Harris CC, Pine SR, Spitz MR, Amos CI, Levin AM, McKeigue PM. Admixture mapping of lung cancer in 1812 African-Americans. Carcinogenesis. 32: 312-7. PMID 21115650 DOI: 10.1093/Carcin/Bgq252 |
0.134 |
|
| 2023 |
Zhong H, Lu W, Tang Y, Wiel C, Wei Y, Cao J, Riedlinger G, Papagiannakopoulos T, Guo JY, Bergo MO, Kang Y, Ganesan S, Sabaawy HE, Pine SR. SOX9 drives KRAS-induced lung adenocarcinoma progression and suppresses anti-tumor immunity. Oncogene. PMID 37258742 DOI: 10.1038/s41388-023-02715-5 |
0.133 |
|
| 2020 |
Malhotra J, Jabbour SK, Pine S. Impact of surveillance frequency on survival in non-small cell lung cancer (NSCLC) survivors. Translational Lung Cancer Research. 8: S347-S350. PMID 32038912 DOI: 10.21037/TLCR.2019.05.04 |
0.133 |
|
| 2018 |
Pine SR. Rethinking gamma-secretase inhibitors for treatment of non-small cell lung cancer: Is Notch the target? Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30104200 DOI: 10.1158/1078-0432.CCR-18-1635 |
0.132 |
|
| 2020 |
Arauz RF, Byun JS, Tandon M, Sinha S, Kuhn S, Taylor S, Zingone A, Mitchell KA, Pine SR, Gardner K, Perez-Stable EJ, Napoles AM, Ryan BM. Whole Exome Profiling of NSCLC Among African Americans. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 32931935 DOI: 10.1016/j.jtho.2020.08.029 |
0.13 |
|
| 2007 |
Pine SR, Mechanic LE, Ambs S, Bowman ED, Chanock SJ, Loffredo C, Shields PG, Harris CC. Lung cancer survival and functional polymorphisms in MBL2, an innate-immunity gene. Journal of the National Cancer Institute. 99: 1401-9. PMID 17848669 DOI: 10.1093/Jnci/Djm128 |
0.129 |
|
| 2010 |
Chaturvedi AK, Caporaso NE, Katki HA, Wong HL, Chatterjee N, Pine SR, Chanock SJ, Goedert JJ, Engels EA. C-reactive protein and risk of lung cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 2719-26. PMID 20421535 DOI: 10.1200/JCO.2009.27.0454 |
0.129 |
|
| 2013 |
Liu W, Jeganathan G, Amiri S, Morgan KM, Ryan BM, Pine SR. Asymmetric segregation of template DNA strands in basal-like human breast cancer cell lines. Molecular Cancer. 12: 139. PMID 24238140 DOI: 10.1186/1476-4598-12-139 |
0.126 |
|
| 2020 |
Dragan M, Nguyen MU, Guzman S, Goertzen C, Brackstone M, Dhillo WS, Bech PR, Clarke S, Abbara A, Tuck AB, Hess DA, Pine SR, Zong WX, Wondisford FE, Su X, et al. G protein-coupled kisspeptin receptor induces metabolic reprograming and tumorigenesis in estrogen receptor-negative breast cancer. Cell Death & Disease. 11: 106. PMID 32034133 DOI: 10.1038/s41419-020-2305-7 |
0.125 |
|
| 2018 |
Pine SR, Sabaawy HE. Editorial: Harnessing the Power of Patient Derived Models of Cancer. Frontiers in Oncology. 8: 349. PMID 30237982 DOI: 10.3389/fonc.2018.00349 |
0.122 |
|
| 2015 |
Ryan BM, Robles AI, McClary AC, Haznadar M, Bowman ED, Pine SR, Brown D, Khan M, Shiraishi K, Kohno T, Okayama H, Modali R, Yokota J, Harris CC. Identification of a functional SNP in the 3'UTR of CXCR2 that is associated with reduced risk of lung cancer. Cancer Research. 75: 566-75. PMID 25480945 DOI: 10.1158/0008-5472.CAN-14-2101 |
0.12 |
|
| 2018 |
Pine SR, Ryan BM. Identifying therapeutic vulnerabilities in lung cancer: application of a chemistry-first approach. Translational Lung Cancer Research. 7: S265-S269. PMID 30393619 DOI: 10.21037/tlcr.2018.09.10 |
0.117 |
|
| 2023 |
Hoang DT, Dinstag G, Hermida LC, Ben-Zvi DS, Elis E, Caley K, Sammut SJ, Sinha S, Sinha N, Dampier CH, Stossel C, Patil T, Rajan A, Lassoued W, Strauss J, ... ... Pine SR, et al. Prediction of cancer treatment response from histopathology images through imputed transcriptomics. Research Square. PMID 37790315 DOI: 10.21203/rs.3.rs-3193270/v1 |
0.114 |
|
| 2022 |
Kwon M, Rubio G, Wang H, Riedlinger G, Adem A, Zhong H, Slegowski D, Post-Zwicker L, Chidananda A, Schrump DS, Pine SR, Libutti SK. Smoking-associated Downregulation of FILIP1L Enhances Lung Adenocarcinoma Progression Through Mucin Production, Inflammation, and Fibrosis. Cancer Research Communications. 2: 1197-1213. PMID 36860703 DOI: 10.1158/2767-9764.CRC-22-0233 |
0.112 |
|
| 2008 |
Martin RC, Barker DF, Doll MA, Pine SR, Mechanic L, Bowman ED, Harris CC, Hein DW. Manganese superoxide dismutase gene coding region polymorphisms lack clinical incidence in general population. Dna and Cell Biology. 27: 321-3. PMID 18466086 DOI: 10.1089/dna.2007.0725 |
0.11 |
|
| 2021 |
Malhotra J, Paddock LE, Lin Y, Pine S, Jabbour SK, Stroup A, Manne S. Racial disparities in follow-up care of early-stage lung cancer survivors. Journal of Clinical Oncology. 39: 12025-12025. DOI: 10.1200/JCO.2021.39.15_SUPPL.12025 |
0.11 |
|
| 2022 |
Chambers AM, Lupo KB, Wang J, Cao J, Utturkar S, Atallah Lanman N, Bernal-Crespo V, Jalal S, Pine SR, Toregrosa-Allen S, Elzey BD, Matosevic S. Engineered natural killer cells impede the immunometabolic CD73-adenosine axis in solid tumors. Elife. 11. PMID 35815945 DOI: 10.7554/eLife.73699 |
0.11 |
|
| 2020 |
Castellano GM, Pine SR. Liquid biopsies in non-small cell lung cancer management: what can we learn from methylation status and mutant allele frequencies? Translational Lung Cancer Research. 9: 951-955. PMID 32953473 DOI: 10.21037/tlcr.2020.04.05 |
0.109 |
|
| 2010 |
Fujita K, Mondal AM, Horikawa I, Nguyen GH, Kumamoto K, Sohn JJ, Bowman ED, Mathe MA, Schetter AJ, Pine SR, Ji H, Vojtesek B, Bourdon J, Lane DP, Harris CC. Abstract 2915: p53 isoforms Δ133p53 and p53β are endogenous regulators of replicative cellular senescence Cancer Research. 70: 2915-2915. DOI: 10.1158/1538-7445.Am10-2915 |
0.105 |
|
| 2006 |
Pine SR, Mechanic LE, Bowman ED, Welsh JA, Chanock SC, Shields PG, Harris CC. MDM2 SNP309 and SNP354 are not associated with lung cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 15: 1559-61. PMID 16896050 DOI: 10.1158/1055-9965.Epi-06-0217 |
0.103 |
|
| 2019 |
Mitchell KA, Shah E, Bowman ED, Zingone A, Nichols N, Pine SR, Kittles RA, Ryan BM. Relationship between West African ancestry with lung cancer risk and survival in African Americans. Cancer Causes & Control : Ccc. PMID 31468279 DOI: 10.1007/s10552-019-01212-z |
0.102 |
|
| 2019 |
Meaney C, Mitchell KA, Zingone A, Brown D, Bowman E, Yu Y, Wenzlaff AS, Neslund-Dudas C, Pine S, Cao L, Schwartz AG, Ryan BM. Circulating Inflammation Proteins Associated with Lung Cancer in African Americans. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 30953795 DOI: 10.1016/J.Jtho.2019.03.014 |
0.102 |
|
| 2013 |
Mondal AM, Horikawa I, Pine SR, Fujita K, Morgan KM, Vera E, Mazur SJ, Appella E, Vojtesek B, Blasco MA, Lane DP, Harris CC. p53 isoforms regulate aging- and tumor-associated replicative senescence in T lymphocytes. The Journal of Clinical Investigation. 123: 5247-57. PMID 24231352 DOI: 10.1172/Jci70355 |
0.101 |
|
| 2015 |
Pine SR, Mechanic LE, Enewold L, Bowman ED, Ryan BM, Cote ML, Wenzlaff AS, Loffredo CA, Olivo-Marston S, Chaturvedi AK, Caporaso NE, Schwartz AG, Harris CC. Differential Serum Cytokine Levels and Risk of Lung Cancer between African and European Americans. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 26711330 DOI: 10.1158/1055-9965.Epi-15-0378 |
0.099 |
|
| 2022 |
Malhotra J, Paddock LE, Lin Y, Pine SR, Habib MH, Stroup A, Manne S. Racial disparities in follow-up care of early-stage lung cancer survivors. Journal of Cancer Survivorship : Research and Practice. PMID 35318568 DOI: 10.1007/s11764-022-01184-1 |
0.097 |
|
| 2014 |
Liu W, Morgan KM, Pine SR. Activation of the Notch1 Stem Cell Signaling Pathway during Routine Cell Line Subculture. Frontiers in Oncology. 4: 211. PMID 25147757 DOI: 10.3389/fonc.2014.00211 |
0.095 |
|
| 2009 |
Olivo-Marston SE, Yang P, Mechanic LE, Bowman ED, Pine SR, Loffredo CA, Alberg AJ, Caporaso N, Shields PG, Chanock S, Wu Y, Jiang R, Cunningham J, Jen J, Harris CC. Childhood exposure to secondhand smoke and functional mannose binding lectin polymorphisms are associated with increased lung cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 18: 3375-83. PMID 19959685 DOI: 10.1158/1055-9965.Epi-09-0986 |
0.094 |
|
| 2012 |
Ryan BM, Calhoun KM, Pine SR, Bowman ED, Robles AI, Ambs S, Harris CC. MDM2 SNP285 does not antagonize the effect of SNP309 in lung cancer. International Journal of Cancer. Journal International Du Cancer. 131: 2710-6. PMID 22487911 DOI: 10.1002/ijc.27573 |
0.094 |
|
| 2007 |
Sabaawy HE, Sandoval C, Guo Q, Yin C, Kulangara A, Lee J, Wormser G, Jayabose S, Pine SR. Lymphoproliferative clonal origin of AIDS-related non-Hodgkin's lymphoma. Leukemia & Lymphoma. 48: 812-5. PMID 17454643 DOI: 10.1080/10428190601173109 |
0.091 |
|
| 2011 |
Mondal AM, Horikawa I, Pine SR, Fujita K, Vojtesek B, Bourdon J, Vera E, Lane DP, Blasco MA, Harris CC. Abstract B1: p53 isoforms, Δ133p53 and p53β, regulate aging-associated T lymphocyte senescence. Cancer Research. 71. DOI: 10.1158/1538-7445.Fbcr11-B1 |
0.086 |
|
| 2009 |
Fujita K, Mondal AM, Horikawa I, Nguyen GH, Kumamoto K, Sohn JJ, Bowman ED, Mathe EA, Schetter AJ, Pine SR, Ji H, Vojtesek B, Bourdon JC, Lane DP, Harris CC. p53 isoforms Delta133p53 and p53beta are endogenous regulators of replicative cellular senescence. Nature Cell Biology. 11: 1135-42. PMID 19701195 DOI: 10.1038/Ncb1928 |
0.078 |
|
| 2014 |
Capaccione K, Hong X, Morgan KM, Liu W, Allen T, Bishop JM, Pine SR. Abstract B17: Sox9 mediates Notch pathway-induced epithelial-mesenchymal transition (EMT) in lung adenocarcinoma. Clinical Cancer Research. 20: B17-B17. DOI: 10.1158/1078-0432.14AACRIASLC-B17 |
0.071 |
|
| Hide low-probability matches. |